Old Web
English
Sign In
Acemap
>
authorDetail
>
Martin Orság
Martin Orság
Palacký University, Olomouc
Biochemistry
Cyclin-dependent kinase 2
Cyclin-dependent kinase
Mitogen-activated protein kinase kinase
Cyclin-dependent kinase 9
4
Papers
226
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
4-Arylazo-3,5-Diamino-1H-Pyrazole Cdk Inhibitors: Sar Study, Crystal Structure in Complex with Cdk2, Selectivity, and Cellular Effects
2006
Journal of Medicinal Chemistry
Vladimír Kryštof
Petr Cankar
Iveta Fryšová
Jan Slouka
George Kontopidis
Petr Džubák
Marian Hajduch
Josef Srovnal
F Walter de AzevedoJr.
Martin Orság
Martina Paprskářová
Jakub Rolcik
Aleš Látr
Peter M. Fischer,‖,○ and
Miroslav Strnad
Show All
Source
Cite
Save
Citations (143)
Antiproliferative activity of olomoucine II, a novel 2,6,9-trisubstituted purine cyclin-dependent kinase inhibitor
2005
Cellular and Molecular Life Sciences
Vladimír Kryštof
Iain W. McNae
Malcolm D. Walkinshaw
P. Fischer
Petr Müller
B Vojtesek
Martin Orság
Libor Havlicek
Miroslav Strnad
Show All
Source
Cite
Save
Citations (47)
Cyclin-dependent kinase inhibitor olomoucine II interacts with CDK2 and CDK9
2005
Cellular & Molecular Biology Letters
Vladimír Kryštof
Martin Orság
M. Paprskarova
Petr Müller
Borivoj Vojtesek
Miroslav Strnad
Show All
Source
Cite
Save
Citations (0)
8-Azapurines as new inhibitors of cyclin-dependent kinases
2005
Bioorganic & Medicinal Chemistry
Libor Havlíček
Kveta Fuksova
Vladimír Kryštof
Martin Orság
Borivoj Vojtesek
Miroslav Strnad
Show All
Source
Cite
Save
Citations (36)
1